Efflux transporters of the human placenta

Advanced Drug Delivery Reviews

Volumn 55, Issue 1, 2003, Pages 125-132

  Young, Amber M ^a   Allen, Courtni E ^a   Audus, Kenneth L ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

BCRP; Drug efflux; MDR1; MRP; Multidrug resistance; P glycoprotein; Placental barrier

Indexed keywords

ACIDS; BIOLOGICAL ORGANS; HORMONES; PROTEINS;

EFFLUX TRANSPORTERS; HUMAN PLACENTA;

DRUG INFUSION;

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; BILE ACID TRANSPORTER; BREAST CANCER RESISTANT PROTEIN; CAMPTOTHECIN; CARRIER PROTEIN; CYTOCHROME P450 3A4; DAUNORUBICIN; DOXORUBICIN; ELACRIDAR; GLUCOCORTICOID; GLUCURONIC ACID; GLUTATHIONE; GLYCOPROTEIN P; HOE 33342; MITOXANTRONE; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER; PREGNANE DERIVATIVE; PROGESTERONE; RECOMBINANT PROTEIN; RHODAMINE 123; STEROID HORMONE; TOPOTECAN; TOXIC SUBSTANCE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XENOBIOTIC AGENT;

DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG TRANSPORT; FETUS RISK; HEALTH; HUMAN; MOTHER; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SYNCYTIOTROPHOBLAST;

EID: 0037457791     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00174-6     Document Type: Article

References (55)

1. Yaffe S.J. Introduction. Drugs in Pregnancy and Lactation. 1998;xiii-xix William and Wilkins, Baltimore, MD.
2. Enders R.J., Blankenship W.F. Comparative placental structure. Adv. Drug Deliv. Rev. 38:1999;3-15.
3. Macfarland A., Abramovich D.R., Ewen S.W.B., Pearson C.K. Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem. J. 26:1994;417-423.
4. St-Pierre M.V., Serrano M.A., Macias R.I.R., Dubs U., Hoechl M., Lauper U., Meier P.J., Marin J.J.G. Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:2000;R1495-R1503.
5. Maliepaard M., Sheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C.L.M., Schinkel A.H., van de Vijver M.J., Scheper R.J., Schellens J.H.M. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61:2001;3458-3464.
6. Cordon-Carlo C., O'Brien J.P., Boccia J., Casals D., Bertino J.R., Melamed M.R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1990;1277-1287.
7. Gruol D.J., Bourgeois S. Chemosensitizing steroids: glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function. Cancer Res. 54:1997;720-727.
8. Dancis J., Liebes L. Drug delivery during pregnancy: Evaluation in vitro of new drugs. Reprod. Fertil. Dev. 7:1995;1485-1489.
9. F. Liu, M.J. Soares, K.L. Audus, Permeability properties of monolayers of the human trophoblast cell line BeWo, Am. J. Physiol. 273 5 (Part 1) (1997) C1596-C1604.
10. Sastry B.V.R. Techniques to study human placental transport. Adv. Drug Deliv. Rev. 38:1999;17-39.
11. Shi F., Soares M.J., Avery M., Liu F., Zhang X., Audus K.L. Permeability and metabolic properties of a trophoblast cell line (HRP-1) derived from normal rat placenta. Exp. Cell Res. 234:1997;147-155.
12. Casey M.L., MacDonald P.C. Section 8: Endocrine changes of pregnancy. Williams Textbook of Endocrinology. 9th Edition:1998;1259-1271.
13. Orlowski S., Mir L.M., Belehradek J. Jr., Garrigos M. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem. J. 317:1996;515-522.
14. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:1999;361-398.
15. Mylona P., Glazier J.D., Greenwood S.L., Slides M.K., Sibley C.P. Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. Mol. Hum. Reprod. 2:1996;693-698.
16. Allikmets R., Schriml L.M., Hutchinson A., Romano-Spica V., Dean M. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:1998;5337-5339.
17. Nakamura Y., Ikeda S., Fukuwara T., Sumizawa T., Tani A., Akiyama S., Yagata Y. Function of P-glycoprotein expressed in placenta and mole. Biochem. Biophys. Res. Commun. 235:1997;849-853.
18. Lankas G.R., Wise L.D., Cartwright M.E., Pippert T., Umbenhauer D.R. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. Reprod. Toxicol. 12:1998;457-463.
19. Smit J.W., Huisman M.T., van Tellingen O., Wiltshire H.R., Schinkel A.H. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104:1999;1441-1447.
20. Pavek P., Fendrich Z., Staud F., Malakova J., Brozmanova H., Laznicek M., Semecky V., Grundmann M., Palicka V. Influence of P-glycoprotein on the Transplacental passage of cyclosporine. J. Pharm. Sci. 90:2001;1583-1592.
21. Utoguchi N., Chandorkar G.A., Avery M., Audus K.L. Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. Reprod. Toxicol. 14:2000;217-224.
22. Ushigome F., Takanaga H., Matsuo H., Yanai S., Tsukimori K., Nakano H., Uchiumi T., Nakamura T., Kuwano M., Ohtani H., Sawada Y. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur. J. Pharmacol. 408:2000;1-10.
23. Tanabe M., Ieiri I., Nagata N., Inoue K., Ito S., Kanamori Y., Takahashi M., Kurata Y., Kigawa J., Higuchi S., Terakawa N., Otsubo K. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther. 297:2001;1137-1143.
24. Vo Q.D., Gruol D.J. Identification of P-glycoprotein mutations causing a loss of steroid recognition and transport. J. Biol. Chem. 274:1999;20318-20327.
25. Shapiro A.B., Fox K., Lam P., Ling V. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone: evidence for a third binding site. Eur. J. Biochem. 259:1999;841-850.
26. Yang C.H., DePinho S.G., Greenberger L.M., Arceci R.J., Horwitz S.B. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of the gravid uterus. J. Biol. Chem. 264:1989;782-788.
27. Ichikawa-Haraguchi M., Sumizawa T., Yoshimura A., Furukawa T., Hiramoto S., Sugita M., Akiyama S. Progesterone and its metabolites: the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland. Biochim. Biophys. Acta. 1158:1993;201-208.
28. Leonessa F., Kim J., Ghiorghis A., Kulawiec R.J., Hammer C., Talebian A., Clarke R. C-7 analogues of progesterone as potent inhibitors of the P-glycoprotein efflux pump. J. Med. Chem. 45:2002;390-398.
29. Christen R.D., McClay E.F., Plaxe S.C., Yen S.S.C., Kim S., Kirmani S., Wilgus L.L., Heath D.D., Shalinsky D.R., Freddo J.L., Braly P.S., O'Quigley J., Howell S.B. Phase I/ pharmacokinetic study of high-dose progesterone and doxorubicin. J. Clin. Oncol. 11:1993;2417-2426.
30. Synold T.W., Dussault I., Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 7:2001;584-590.
31. Schuetz E.G., Brimer C., Schuetz J.D. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone receptor pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol. Pharmacol. 54:1998;1113-1117.
32. Zhang H., LeCluyse E., Liu L., Hu M., Matoney L., Zhu W., Yan B. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch. Biochem. Biophys. 368:1999;14-22.
33. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:2000;1295-1302.
34. Rappa G., Lorico A., Flavell R.A., Sartorelli A.C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res. 57:1997;5232-5237.
35. Seelig A., Blatter X.L., Wohnsland F. Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison. Int. J. Clin. Pharmacol. Ther. 38:2000;111-121.
36. Kruh G.D., Zeng H., Rea P.A., Liu G., Chen Z., Lee K., Belinsky M.G. MRP subfamily transporters and resistance to anticancer agents. J. Bioenerg. Biomemr. 33:2001;493-501.
37. Mor-Cohen R., Zivelin A., Rosenberg N., Shani M., Muallem S., Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J. Biol. Chem. 276:2001;36923-36930.
38. Flens M.J., Zaman G.J.R., van der Valk P., Izquierdo M.A., Schroeijers A.B., Scheffer G.L., van der Groep P., de Haas M., Meijer C.J.L., Scheper R.J. Tissue distribution of the multidrug resistance protein. Am. J. Pathol. 148:1996;1237-1247.
39. Sugawara I., Akiyama S., Scheper R.J., Itoyama S. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP. Cancer Lett. 112:1997;23-31.
40. Pascolo L., Fernetti C., Pirulli D., Bogoni S., Garcia-Mediavilla M.V., Spano A., Puzzer D., Tiribelli C., Amoroso A., Crovella S. Detection of MRP1 mRNA in human tumors and tumor cell lines by in situ RT-PCR. Biochem. Biophys. Res. Commun. 275:2000;466-471.
41. Pascolo L., Fernetti C., Garcia-Mediavilla M.V., Ostrow J.D., Tiribelli C. Mechanisms for the transport of unconjugated bilirubin in human trophoblastic BeWo Cells. FEBS Lett. 495:2001;94-99.
42. Kawabata S., Oka M., Shiozawa K., Tsukamoto K., Nakatomi K., Soda H., Fukuda M., Ikegami Y., Sugahara K., Yamada Y., Kamihira S., Doyle L., Ross D., Kohno S. Breast cancer resistance protein directly confers SN-38 resisitance of lung cancer cells. Biochem. Biophys. Res. Commun. 280:2001;1216-1223.
43. Brangi M., Litman T., Ciotti M., Nishiyama K., Kohlhagen G., Takimoto C., Robey R., Pommier Y., Fojo T., Bates S. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in mxr-expressing cells. Cancer Res. 59:1999;5938-5946.
44. Scheffer G., Maliepaard M., Pinjnenborg A., van Gastelen M., de Jong M., Schroeijers A., van der Kolk D., Allen J., Douglas R., van der Valk P., Dalton W., Schellens J., Scheper R. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone and topotecan-resistant cell lines. Cancer Res. 60:2001;2589-2593.
45. Tan B., Piwnica-Worms D., Ratner L. Multidrug resistance transporters and modulation. Curr. Opin. Oncol. 12:2000;450-458.
46. de Bruin M., Miyake K., Litman T., Robey R., Bates S. Reversal of resistance by GF120918 in cell line expressing the ABC half-transporter MXR. Cancer Lett. 146:1999;117-126.
47. Robey R., Honjo Y., van de Laar A., Miyake K., Regis J., Litman T., Bates S. A functional assay for detection of the mitoxantrone resistance protein MXR (ABCG2). Int. J. Biochem. Biophys. 1512:2001;171-182.
48. Litman T., Brangi M., Hudson E., Fetsch P., Abati A., Ross D., Miyake K., Resau J., Bates S. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci. 113:2000;2001-2021.
49. Ross D., Yang W., Abruzzo L., Dalton W., Schneider E., Lage H., Dietel M., Greenberger L., Coli S., Doyle L. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J. Natl. Cancer Inst. 91:1999;429-433.
50. Jonker J., Smit J., Brinkhuis R., Maliepaard M., Beijnen J., Schellens J., Schinkel A. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92:2000;1651-1656.
51. Fardel O., Payen L., Courtois A., Vernhet L., Lecureur V. Regulation of biliary drug efflux pump expression by hormones and xenobiotics. Toxicology. 167:2001;37-46.
52. Xie W., Radominska-Pandya A., Shi Y., Simon C.M., Nelson M.C., Ong E.S., Waxman D.J., Evans R.M. An essential role for nuclear receptors SXR/PXR in Detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. USA. 98:2001;3375-3380.
53. Pascual M.J., Macias R.I., Garcia-del-Pozo J., Serrano M.A., Marin J.J.G. Enhanced efficiency of the placental barrier to cisplatin through binding to glycocholic acid. Anticancer Res. 21:2001;2703-2708.
54. El-Mir M.Y., Eleno N., Serrano M.A., Bravo P., Marin J.J.G. Bicarbonate-induced activation of taurocholate transport across the basal plasma membrane of the human term trophoblast. Am. J. Physiol. 260:1991;G887-G894.
55. Marin J.J.G., Serrano M.A., El-Mir M.Y., Eleno N., Boyd C.A.R. Bile acid transport by basal membrane vesicles of human term placental trophoblast. Gastroenterology. 99:1990;1431-1438.